Infections are common among patients with liver cirrhosis. They occur more often in cirrhotic
patient groups than in the general population and result in higher mortality. One reason for …

Introduction Spontaneous bacterial peritonitis (SBP) is a common infection in patients with
cirrhosis and ascites and is associated with significant risk of mortality. Therefore, it is …

Aim Tolvaptan, an oral active vasopressin V2 receptor antagonist, is widely used for hepatic
edema in Japan, but its clinical benefits have yet to be fully clarified. The present study …

Aim It is well known that the use of proton pump inhibitor (PPI) is widespread in patients with
liver cirrhosis. PPI counteracts H2 receptor inhibitor (H2RA) with its strong acid suppression …

Background Spontaneous bacterial peritonitis (SBP) is a life-threatening complication in
patients with advanced cirrhosis. Prophylactic Norfloxacin used to be considered effective in …

自发性细菌性腹膜炎是肝硬化腹水常见的一种并发症. 其发病率高, 病情进展快, 病死率高.
目前国内外有关自发性细菌性腹膜炎的临床诊断标准尚不统一, 且有些患者的临床症状不典型 …

自发性细菌性腹膜炎(spontaneousbacterialperitonitis, SBP) 是肝硬化患者失代偿期最主要,
最常见的感染并发症, 其发病率高, 病情进展快, 病死率高, 预后差. 有些患者缺乏典型的临床表现 …

Tóm tắt Giới thiệu: Viêm phúc mạc nhiễm khuẩn nguyên phát (SBP) là một bệnh nhiễm
trùng phổ biến ở bệnh nhân xơ gan và cổ trướng và có liên quan đến nguy cơ tử vong cao …

In addition to antibiotic therapy for treatment of peritonitis, biologics have also been found to
exhibit both anti-inflammatory and inflammation-resolving properties. Here, we first …

Spontaneous bacterial peritonitis (SBP) is a common complication of cirrhotic ascites, and
has a high incidence rate, rapid progression, and a high fatality rate. At present, there are no …